Verónica Salgado, the Ph.D. student at the TR2Lab, presented an e-poster at the 33rd Conference of the European Wound Management Association (EWMA), held in Milan, Italy from May 3rd to May 5th, 2023.

The title of the oral communication given by Verónica Salgado was “Effect of autologous platelet-rich plasma from patients with chronic wounds in cell viability, migration, and angiogenesis” (1).  To gain a better understanding of the cellular mechanism of PRP, which is still unknown, she presented results obtained from assays conducted with endothelial cells and dermal fibroblasts treated with PRP from patients with chronic wounds. The experiments demonstrated that the presence of PRP led to increased endothelial cell viability and the percentage of wound closure by fibroblasts compared to PPP. In clinical settings, this implies a reduction in healing time, a lower risk of infection, and an improvement in the patient’s quality of life. Additionally, PRP appears to sustain the viability of endothelial cells, suggesting that this therapy may contribute to the early stages of the wound-healing process.

(1) Original title of the oral communication: “Effect of autologous platelet-rich plasma from patients with chronic wounds in cell viability, migration, and angiogenesis” Salgado-Pacheco Verónica 1,2; Martín Mancera Cristina 1,2; Casals-Zorita Marta 1,3; Masó-Albareda Clara 1,3; Ferrer-Solà Marta 1,3; Cullell-Dalmau, Marta 2,4; Sarri-Plans Elisabet 1,2; Otero-Viñas, Marta 1,2.

1- Tissue Repair and Regeneration Laboratory (TR2Lab), Institute for Research and Innovation in Life and Health Sciences in Central Catalonia (IrisCC), Vic, Barcelona, Spain; 2- University of Vic – Central University of Catalonia, Vic, Barcelona, Spain; 3- Hospital Universitari de la Santa Creu de Vic, Vic, Barcelona, Spain; 5- Hospital Universitari de Vic, Vic, Barcelona, Spain; 4- Bi-Squared, Institute for Research and Innovation in Life and Health Sciences in Central Catalonia (IrisCC), Vic, Barcelona, Spain.